1 photo

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• Figure 1: Food and Drug Administration’s (FDA) Typical Drug Development and Approval Process

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 1 favorite
  • 6,778 views
  • Date uploaded: 2017-07-19
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao17564, investigationalnewdrugs, bla, biologicslicenseapplication, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, compac, compassionateuseadvisorycommittee, fda, foodanddrugadministration, ind, investigationalnewdrugapplication, irb, institutionalreviewboard, nda, newdrugapplication, nyu, newyorkuniversity
  • Visibility: public